Page last updated: 2024-12-06

ethyl hexanoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ethyl hexanoate is a colorless liquid with a fruity, pineapple-like odor. It is commonly used as a flavoring agent and fragrance in food, beverages, and cosmetics. It is also used as a solvent and plasticizer. Ethyl hexanoate is typically synthesized by the esterification of hexanoic acid with ethanol, often catalyzed by a strong acid such as sulfuric acid. It is considered to be relatively safe for human consumption and use in cosmetics. It is studied for its potential applications in various fields, including food science, cosmetics, and pharmaceuticals, due to its pleasant aroma and its ability to interact with biological systems.'

ethyl hexanoate : A fatty acid ethyl ester obtained by the formal condensation of hexanoic acid with ethanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID31265
CHEBI ID86055
SCHEMBL ID37297
MeSH IDM0212146

Synonyms (61)

Synonym
LS-13515
ethyl hexanoate (caproate) (natural)
ethyl hexanoate (caproate)
capronic ether absolute
ai3-15347
fema no. 2439
einecs 204-640-3
brn 1701293
nsc 8882
ccris 6555
acetic acid, butyl-, ethyl ester
nsc-8882
123-66-0
ethyl hexanoate
nsc8882
wln: 5vo2
ethyl butyl acetate
ethyl hexoate
ethyl caproate
hexanoic acid, ethyl ester
ethyl hexanoate, >=98%, fcc, fg
ethyl hexanoate, natural, >=98%, fcc, fg
ethyl hexanoate, >=99%
caproic acid ethylester
caproic acid ethyl ester
FT-0654031
H0108
hexanoic acid ethyl ester
LMFA07010434
we(2:0/6:0)
NCGC00255157-01
cas-123-66-0
dtxsid3021980 ,
dtxcid301980
tox21_301217
AKOS008947981
unii-flo6yr1sht
flo6yr1sht ,
SCHEMBL37297
ethyl capronate
ethyl hexanoate [fhfi]
ethyl hexanoate [fcc]
ethyl caproate [mi]
2-ethyl hexanoate
ethyl n-hexanoate
CHEBI:86055
ethyl n-hexanoat
ethyl ester of hexanoic acid
n-caproic acid ethyl ester
J-004970
mfcd00009511
ethyl hexanoate, saj special grade, >=99.0%
ethyl hexanoate, analytical reference material
hexanoic acid-ethyl ester
fema 2439
ethyl butyl acetate (dot)
2159-19-5
hexanoic acid-ethyl ester 10 microg/ml in acetonitrile
Q905406
?ethyl caproate
caproic acid ethyl ester, ethyl caproate

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
fatty acid ethyl esterA fatty acid ester that is the carboxylic ester obtained by the formal condensation of a fatty acid with ethanol.
hexanoate esterAny fatty acid ester where the carboxylic acid component is hexanoic (also known as caproic) acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (61)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (1.64)18.2507
2000's21 (34.43)29.6817
2010's29 (47.54)24.3611
2020's10 (16.39)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 63.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index63.81 (24.57)
Research Supply Index4.13 (2.92)
Research Growth Index5.31 (4.65)
Search Engine Demand Index103.38 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (63.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.64%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other60 (98.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]